pinal cord ependymomas are slow growing, not very infiltrative, and well-demarcated tumors of neuroectodermal origin arising from ependymal cells in the central canal of the spinal cord and filum terminale, 1, 8, 21, 26, 31, 40 or even from heterotopic ependymal cells in the spinal canal. 5, 37 These ependymomas occur more frequently in middle age (40-60 years of age) and represent 60% of cases of intramedullary spinal cord tumors. 3, 4, 9, 13, 16, 18, 23, 24, 32, 34, 35, 38, 43 Although spinal cord ependymomas are the most commonly occurring intramedullary neoplasms in adults, spinal anaplastic ependymomas appear to be ex ceed ingly rare; 7,38 histologically, the malignant subtype cor re sponds to WHO Grade III tumors.
Primary spinal anaplastic ependymomas arise from the spinal cord. Distinct from lesions that result from dissemination of intracranial anaplastic ependymomas and recurrent or metastatic spinal anaplastic ependymomas, PSAEs have been described in the past only in case studies 5, 11, 22, 30, 32, 39 or as part of a series of spinal cord ependymomas. 3, 4, 7, 15, 26, 31, 41, 43 Accordingly, the clinical characteristics and treatment outcomes of PSAEs have not been emphasized and are less well understood than those of benign or classic ependymomas (WHO Grade II). Given the relative paucity of literature addressing the primary spinal anaplastic variant, we review our experience with these tumors, with analysis of their clinical presentation, radiographic imaging, surgery, complications, recurrence, and survival. The role of radiation therapy and chemotherapy in the management of this rare subset of tumors is also described.
Methods

Study Population
After excluding anaplastic ependymomas with an infratentorial genesis and cervical spinal canal extension, Outcomes in treatment for primary spinal anaplastic ependymomas: a retrospective series of 20 patients we analyzed 26 patients with anaplastic ependymomas with spinal cord involvement who were treated at Huashan Hospital between January 1999 and December 2008. In these 26 cases, 2 patients who developed spinal seeding after an operation for intracranial anaplastic ependymomas were excluded. Four patients who developed spinal recurrences or remote disseminations were also excluded from further analysis. Thus, a total of 20 patients with PSAEs were included, and their medical records were reviewed. Pathological specimens of all patients were available and classified as anaplastic ependymomas (WHO Grade III) according to the WHO classification of 2000 and 2007; typical examples are shown in Fig. 1 . All patients were uniformly evaluated with preoperative MRI.
Operation and Follow-Up
In all patients, a posterior midline approach was performed; the surgical technique has been previously described. 16, 44 After the operation patients were followed up by clinical examinations or telephone interviews. Neurological function was evaluated using the AIS (http://www. asia-spinalinjury.org) and the McCormick classification system. 27 Grades were assigned retrospectively on the basis of documented preoperative and postoperative examinations. All patients underwent follow-up imaging studies.
Results
Epidemiological Characteristics
During the study period, 273 patients with spinal ependymal tumors underwent surgery, 20 of which were for PSAEs (Fig. 2 ). There were 13 men and 7 women, ranging in age from 2 to 67 years old (mean 31.9 years old; Table 1 ). Two patients had tumors localized in the medullocervical cord, 6 were in the cervical cord, 4 were in the cervicothoracic cord, 6 were in the thoracic cord, and 2 were in the thoracic cord-conus medullaris. The tumors spanned 2 vertebral levels in 2 patients, 3 vertebral levels in 5 patients, 4 vertebral levels in 7 patients, and 5 or more vertebral levels in 6 patients.
Clinical and Radiographic Features
The average duration of the clinical history was 9.3 months, with a range of 20 days to 48 months. Table 1 summarizes clinical features in the patients with PSAE. The most common symptom was limb weakness in 18 patients (90%), followed by limb numbness in 15 patients (75%), bowel or bladder dysfunction in 12 patients (60%), and pain in the neck or back or radiating to the extremities in 10 patients (50%). Objective neurological signs were detected in only 14 patients (70%) at the time of diagnosis. These signs included motor dysfunction in 14 (70%), hypesthesia in 11 patients (55%), ataxia in 7 (35%), lower cranial nerve paralysis in 2 (10%), and muscular atrophy in 2 (10%).
Twelve patients had neuroimaging or radiology reports available for review. The T1-weighted images were hypointense to isointense in 10 cases, with 2 tumors exhibiting minimal hyperintense signaling. All tumors were heterogeneously hyperintense on T2-weighted images. Five patients presented with tumor-associated cysts. Administration of contrast medium resulted in more or less marked enhancement in all ependymomas, with 6 exhibiting a heterogeneous pattern (irregular or patchy enhancement; Fig. 3 ), 5 a homogeneous pattern, and 1 with a heterogeneous pattern and cyst wall rim enhancement (Fig.  4) . In all 12 patients, 10 ependymomas were located in the center of the spinal cord, 1 in the intramedullary cord with an exophytic component (Fig. 5) , and 1 entirely in the intradural-extramedullary space.
Surgical Outcome
All patients underwent an initial surgical procedure. A GTR was achieved in 17 patients (85%) according to the surgical reports and postoperative MR images. An STR was achieved in 3 patients (15%) because of a poorly defined cleavage plane between the tumor and spinal cord. Surgical outcome summaries are provided in Table 2 .
Postoperatively, 3 patients with a cervicothoracic or medullocervical tumor required a tracheostomy, and 2 patients developed ventilator-associated pneumonia necessitating intravenous antibiotics. One patient developed a urinary tract infection. There were no recorded complications of CSF leakage, deep venous thrombosis, or pulmonary embolism in any of the patients. The length of stay was prolonged in the patients with sustained complications. No patient had evidence of instability, neurological morbidity, or other significant complications.
Of the 20 patients, 2 developed a local recurrence and 1 developed a distant recurrence. Specifically, Case 13, who received GTR and adjuvant radiotherapy, developed lung metastasis; Case 6, who only received STR, developed a local recurrence; and Case 20, who received STR followed by adjuvant radiotherapy, also developed a local recurrence in the radiation field. 
Neurological Function Outcome
At the time of admission, neurological function was scored according to the AIS (Table 1 ) and the McCormick classification system (Table 2) . Three patients (15%) scored C, 15 (75%) scored D, and 2 (10%) scored E on the AIS. Twelve patients (60%) were classified as Grade I, 4 (20%) as Grade II, and 4 (20%) as Grade III on the McCormick scale.
Immediately after surgery, 12 patients (60%) had un- changed neurological function; the condition of 8 patients deteriorated, but 3 of these 8 patients (15%) experienced only transient deterioration and later recovered to the preoperative status in follow-up.
Ten patients who were still alive were recently followed up. Two patients (20%) scored C, 6 (60%) scored D, and 2 (20%) scored E on the AIS. In terms of the McCormick scale, 8 patients (80%) scored Grade I, 1 (10%) scored Grade II, and 1 (10%) had a moderate to severe deficit and required assistance to ambulate (Grade III).
Adjuvant Therapy
Radiation therapy to the tumor bed and surrounding spinal cord was used postoperatively in 9 patients, and 6 were also treated with chemotherapy as adjuvant treatment. Documented regimens included a single agent (temozolomide) or a combination of teniposide and semustine. There were 5 patients in this cohort who never received radiation therapy and chemotherapy at any time during their treatment. One was unknown.
Follow-Up
The length of follow-up was calculated from the date of surgery at our department to the patient's latest clinic visit or telephone interview. Case 9, with a cervicothoracic tumor, died of respiratory dysfunction 6 days after the operation. Case 8, with a cervicothoracic tumor, died of severe pneumonia related to his neurological condition 5 months after the operation. Case 13, with a cervical tumor, died of lung metastasis from the initial site after the operation. Cases 6 and 20, with a cervicothoracic and medullocervical tumor, respectively, developed residual tumor progression after STR and died 23 and 24 months later, respectively. Five patients were lost to follow-up. Ten living patients were followed up from 51 to 129 months (mean 83.5 months). The 5-and 10-year overall survival rates of patients were both 67.9%, based on Kaplan-Meier estimates (Fig. 6 ).
Discussion
Spinal cord ependymomas are the most common intramedullary spinal neoplasms in adults, and many studies of them have been conducted. 43 However, compared with classical ependymomas, little is known regarding PSAEs, which are clinical entities distinct from anaplastic ependymomas disseminated from intracranial space, anaplastic tumors that arise from infratentorial space and extend into the spinal canal, and recurrent or metastatic spinal anaplastic ependymomas. We report a series of 20 consecutive cases of PSAE that underwent surgical treatment at our department in the past 10 years. These PSAEs accounted for 7.3% of spinal ependymal tumors and 1.2% of spinal cord tumors in our series. Primary spinal anaplastic ependymomas developed most commonly in middle-aged men, and tended to have a male predominance, with a male to female ratio of 1.86:1. Symptoms and signs developed slightly more rapidly when compared with the data reported for classic spinal cord ependymomas. The mean preoperative course was 9.3 months in our series as opposed to a 32.3-35 month course in patients with Grade II ependymomas. 18, 21, 24 These PSAEs developed most frequently in cervical and thoracic spinal cords, and were centrally located like classic ependymomas. Less commonly, they presented as exophytic tumors arising from the intramedullary portion or as intradural-extramedullary tumors arising from heterotopic ependymal cells of the spinal canal. Clinical presentation was nonspecific, and symptoms and signs varied according to the size and location of the tumor, and were related to nerve root irritation and mass effect. In our series, most of them generally demonstrated low T1 and high T2 signal intensity that was often heterogeneous, and contrast enhancement was homogeneous or heterogeneous. It appeared that the tumors shared similar MRI characteristics with classic spinal cord ependymomas 10, 25, 29 and are difficult to differentiate from the classic type. However, a sharply defined and enhanced border on contrast MR images may be a feature of classic ependymomas. 10, 29 It is widely accepted that the first-line therapy for spinal cord ependymoma is surgery. 3, 4, 6, 7, 9, 13, 15, 16, [18] [19] [20] 23, 24, 26, 27, 31, 32, 34, 35, 38, 41, 43 Modern microsurgical techniques have resulted in a greater percentage of GTRs. Although anaplastic ependymomas are more aggressive than classic ependymomas, Prayson et al. 33 found that anaplastic ependymomas, like lower-grade ependymomas, tended to be well demarcated from the surrounding spinal cord, rather than diffusely infiltrative. Thus, GTR of PSAEs should be advocated despite their malignant nature. The same characteristic was also found in our patients with PSAE. We believe that PSAEs are potentially curable and should be treated with radical removal, although this is possible only in cases in which there is a plane of cleavage to be found. Gross-total resection has been achieved in patients with PSAE in some studies. 15, 26, 31 The most important factor in determining the surgical objective is the plane between the tumor and the spinal cord. 38 Radical removal was attempted if a plane of cleavage was found in PSAE, and we attempted to remove as much tumor tissue as possible without causing damage to the cord. If the tumor/spinal cord interface is not apparent, it is likely that an infiltrative tumor is present and resection may be discontinued. A poorly defined cleavage plane was found between the tumor and the spinal cord in only 3 of 20 patients in our series, and these patients therefore received an STR. Assuming that a total removal of the lesion was achieved, good control could be achieved and the local recurrence rates in patients with PSAE would be low. 15, 41 However, some authors have reported that PSAEs had a high potential for recurrence or dissemination anywhere in the neuraxis, and dissemination may even occur in the absence of a local recurrence. 5, 22, 32 In the 15 patients who received follow-up in our series, 2 patients who underwent STR died due to recurrence, 10 patients who underwent GTR remain alive, and only 3 patients who underwent GTR died due to complications and distant dissemination. It appeared that GTR may be associated with a better outcome. We also found that the location of the tumor may be a significant factor associated with a poor outcome. All 5 of the patients who died during the follow-up period in our series had tumors involving the cervical cord.
Ependymomas are relatively sensitive to radiation therapy. Results from clinical series have shown that postoperative radiation therapy improved local control and survival in incomplete resection of spinal cord ependymomas. 26 ,41, 43 Lin et al. 26 reported 1 patient with spinal anaplastic ependymoma treated using STR who received no postoperative radiation therapy and subsequently developed leptomeningeal seeding 9 months after surgery. Therefore, adjuvant radiation therapy should be considered for these high-grade tumors. Some authors regarded radiation therapy for spinal anaplastic ependymomas as the gold standard in treatment, and recommended postoperative radiation therapy regardless of resection grade. 6, 14, 15, 27, 38, 41, 42 Local field radiation is the common choice, whereas some authors suggested that craniospinal radiation could be considered. 19 Several investigators reported that patients with PSAEs had a good survival rate (50%), or even 100% after GTR and radiation therapy.
15,41
However, recurrence at its primary site or dissemination of the tumor with seeding along the subarachnoid spaces may occur despite GTR and postoperative irradiation.
22
Of our 9 patients who received postoperative radiation therapy, 1 died due to a local recurrence after an STR, and 1 died of lung metastasis in the absence of a local recurrence following GTR. It is difficult to assess the role of adjuvant radiation therapy with respect to recurrence or dissemination due to the significant association of these variables with the extent of resection.
Chemotherapy could lead to a decrease in tumor size to facilitate surgery, and may have an impact on survival or quality of life.
2 In our series, chemotherapy with single-agent temozolomide or a combination of teniposide and semustine was used in 5 patients who underwent GTR and radiation therapy and in 1 patient who underwent STR and radiation therapy. Only the patient who underwent STR died. However, there was no evidence that the addition of chemotherapy to radiation therapy in PSAEs improves outcome. There is a lack of literature on the role of chemotherapy in PSAEs, and only a few studies have been published on the role of chemotherapy in spinal ependymomas. 2, 20, 43 Thus, the benefit of adjuvant chemotherapy in PSAE remains to be defined. In particular, we have yet to determine if a more aggressive chemotherapy treatment might be more advantageous in terms of patient survival rates in comparison with traditional schemes. However, chemotherapy is sometime considered as a salvage option if a patient is unable to receive surgical treatment or radiation therapy.
Limitations of our study include the small sample size of our series as well as the retrospective nature of the analysis. Prospective studies will be necessary for future guidance of clinical decision making. This study has not analyzed the molecular markers and genotypes that may be linked to patient outcomes. In addition, because the histological assessment of anaplasia (defined as hypercellularity, cellular and nuclear pleomorphism, frequent mitosis, pseudopalisading necrosis, and microvascular proliferation) can be difficult and subjective, 12, 17, 36 further molecular and cytogenetic analyses should be conducted to distinguish anaplastic from classic ependymomas. Nonetheless, we have presented useful insights into the management of patients with PSAEs in this study.
Conclusions
In this study, we report a series of 20 consecutive patients with PSAEs. Our data show PSAEs exhibit a more rapid growth pattern and are occasionally invasive. In particular, patients with tumors involving the cervical spinal cord have a poor outcome. Our results suggest good survival rates in patients with PSAEs who have received GTR; nevertheless, the small sample size of our series limits firm statistical results. The role of adjuvant radiation therapy and chemotherapy for PSAEs should be further defined in the future.
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